AttendingMemorial Sloan Kettering Cancer CenterNew York, New York, United States
Disclosure information not submitted.
Paper 05 - SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS
Thursday, November 14, 20248:30 AM – 10:00 AM PST
Paper 22 - A MULTI-CENTER PHASE II STUDY OF THE ANTI-GD2 HUMANIZED MONOCLONAL ANTIBODY NAXITAMAB IN COMBINATION WITH GM-CSF IN RECURRENT OSTEOSARCOMA.
Thursday, November 14, 20241:45 PM – 3:15 PM PST